Who are Macrogol 3350 plus ascorbic acid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Polyethylene glycol + ascorbate, CitraFleet, Miralax-Gatorade Prep, Moviprep（1-day treatment）, MOVIPREP, 2-Day Split-Dosing.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/macrogol-3350-plus-ascorbic-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Macrogol 3350 plus ascorbic acid — Competitive Intelligence Brief

Macrogol 3350 plus ascorbic acid (Macrogol 3350 plus ascorbic acid) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic laxative bowel preparation. Area: Gastroenterology.

marketed Osmotic laxative bowel preparation Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Macrogol 3350 plus ascorbic acid (Macrogol 3350 plus ascorbic acid) — Fundación Canaria Rafael Clavijo para la Investigación Biomédica. Macrogol 3350 plus ascorbic acid is an osmotic laxative bowel preparation that draws water into the intestinal lumen to promote evacuation, with ascorbic acid enhancing tolerability and reducing volume requirements.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Macrogol 3350 plus ascorbic acid TARGET	Macrogol 3350 plus ascorbic acid	Fundación Canaria Rafael Clavijo para la Investigación Biomédica	marketed	Osmotic laxative bowel preparation
Polyethylene glycol + ascorbate	Polyethylene glycol + ascorbate	Parc de Salut Mar	marketed	Osmotic laxative bowel preparation agent
CitraFleet	CitraFleet	Norgine	marketed	Osmotic laxative bowel preparation
Miralax-Gatorade Prep	Miralax-Gatorade Prep	VA Office of Research and Development	marketed	Osmotic laxative bowel preparation agent
Moviprep（1-day treatment）	Moviprep（1-day treatment）	Nihon Pharmaceutical Co., Ltd	phase 3	Osmotic laxative bowel preparation agent
MOVIPREP, 2-Day Split-Dosing	MOVIPREP, 2-Day Split-Dosing	Norgine	phase 3	Osmotic laxative bowel preparation	Osmotic agent (polyethylene glycol 3350)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic laxative bowel preparation class)

Norgine · 2 drugs in this class
Fundación Canaria Rafael Clavijo para la Investigación Biomédica · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Macrogol 3350 plus ascorbic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/macrogol-3350-plus-ascorbic-acid. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab